SUMICHEM
Sumitomo Chemical India Limited
Each stock's 10,000-path forecast, rendered as light.
Sumitomo Chemical India Limited (SUMICHEM) Stock Analysis & Case Study
Is SUMICHEM a good buy? The data-driven verdict.
Sumitomo Chemical India Limited (SUMICHEM) trades at ₹525,on the numbers it mixed signals, a Downstox Snapshot Score of 45/100.
On the numbers, Sumitomo Chemical India Limited (SUMICHEM) mixed signals, a Downstox Snapshot Score of 45/100, weighing expensive at 45.9× earnings, ROE of 16.2%, a 54% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SUMICHEM fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SUMICHEM ranks against the 2,373 companies in our screener
- SUMICHEM's market cap of 26,602 Cr ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's book value of ₹68 ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's promoter holding of 75.0% ranks in the top 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's 3-year profit (PAT) growth of 2.0% ranks in the 31st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's 3-year revenue growth of -3.0% ranks in the 18th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's debt-to-equity ratio of 0.02x is lower than 94% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is SUMICHEM overvalued? SUMICHEM P/E vs peers
SUMICHEM trades at 45.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SUMICHEM share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 6.4y of SUMICHEM history (15%/yr drift, 37%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SUMICHEM 2027 | ₹347 | ₹556 | ₹891 | +4% |
| SUMICHEM 2028 | ₹296 | ₹580 | ₹1,138 | +9% |
| SUMICHEM 2029 | ₹272 | ₹605 | ₹1,348 | +14% |
| SUMICHEM 2030 | ₹246 | ₹632 | ₹1,620 | +18% |
| SUMICHEM 2031 | ₹230 | ₹659 | ₹1,890 | +24% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SUMICHEM goes up, or doubles?
The bull case for SUMICHEM
- SUMICHEM's return on equity of 16.2% ranks in the 75th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUMICHEM's return on capital employed of 22.1% ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,348.
The bear case & risks
- SUMICHEM's P/E of 46.6x is lower than 29% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹272.
SUMICHEM volatility & expected range, how bumpy is the ride?
Over the last 6.4 years SUMICHEM compounded at 15%/year with annualized volatility of 37%. That volatility implies a 1-year 80% range of ₹347-₹891, the honest backbone behind any single price target.
SUMICHEM price forecast, the full 60-month probability fan
SUMICHEM price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SUMICHEM hits common targets within the simulated horizon?
Full multi-horizon detail on the SUMICHEM price target & forecast page.
SUMICHEM Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SUMICHEM scores 5/8, mixed financial health.
SUMICHEM MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy SUMICHEM with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 32.72% | 3.1× |
| Zerodha | 32.69% | 3.1× |
| Groww | 32.78% | 3.1× |
| Dhan | 32.69% | 3.1× |
| Kotak NeoCHEAPEST | 32.68% | 3.1× |
| Paytm Money | 32.96% | 3.0× |
| Pocketful | 32.89% | 3.0× |
| Fyers | 33.33% | 3.0× |
| Anand Rathi | 32.69% | 3.1× |
| Bajaj Broking | 33.00% | 3.0× |
| Share India | 32.75% | 3.1× |
Compare every broker on the SUMICHEM MTF page.
About Sumitomo Chemical India Limited: sector, index & market-cap context
Sumitomo Chemical India Limited (SUMICHEM) is a mid-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹26,215 Cr. See more stocks on our screener.
How the SUMICHEM Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Sumitomo Chemical India Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SUMICHEM analysis, FAQs
Is Sumitomo Chemical India Limited (SUMICHEM) a good buy?
On the numbers, Sumitomo Chemical India Limited (SUMICHEM) mixed signals, a Downstox Snapshot Score of 45/100, weighing expensive at 45.9× earnings, ROE of 16.2%, a 54% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SUMICHEM overvalued or undervalued?
SUMICHEM trades at 45.9× earnings, expensive versus the ~22× long-run Nifty average.
What is the SUMICHEM share price target for 2031?
SUMICHEM's probability-weighted 2031 median target is ₹659, with an 80% range of ₹230-₹1,890 (10,000-path Monte-Carlo).
What is the probability SUMICHEM doubles in 5 years?
The modelled probability of SUMICHEM reaching ₹1,066 (2×) within 5 years is 28%.
What is the bull case for SUMICHEM?
SUMICHEM's return on equity of 16.2% ranks in the 75th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. SUMICHEM's return on capital employed of 22.1% ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in SUMICHEM?
SUMICHEM's P/E of 46.6x is lower than 29% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.